Ai Feedback
Exact(9)
Conclusions: We conclude that consumption of a commercially available oat cereal product for 6 months is safe for children with celiac disease beginning a gluten-free diet.
Our study – the longest statin treatment in MS patients reported thus far, and the first clinical trial examining a combination treatment of atorvastatin with IFN-β – suggests that treatment with high-dose atorvastatin over a period of 9 months is safe and well tolerated in the majority of patients.
The authors concluded that monotherapy with etanercept for 3 months is safe, well tolerated, and associated with clinical improvement in the symptoms of RA.
It is a commonly used yellow food dye, and it is nontoxic: a daily dose of 12 g for 3 months is safe.
Our study confirmed that lutein supplementation at 10 30 mg/day for up to 6 months is safe, with fewer adverse effects than multivitamin.
Delaying gluten exposure until the age of 12 months is safe but does not substantially reduce the risk for islet autoimmunity in genetically at-risk children.
Similar(50)
A recent trial at New York University found that implantation in children as young as 6 months was safe.
The food agency was mirroring restrictions imposed on Dec. 30 by the Department of Agriculture, which believes that healthy animals younger than 30 months are safe.
Another study, by researchers at Baylor University Medical Center in 2008, reported that taking curcumin daily in moderate doses for up to three months was safe.
In summary, we report that treatment with atorvastatin over 18 months was safe and well tolerated in adult patients with recent-onset type 1 diabetes.
In summary, we report that treatment with high-dose atorvastatin over 9 months was safe and well tolerated in the majority of our patients, regardless of IFN-β co-medication.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com